Clinical trials
Not yet recruiting Phase 2 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 1 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Center, Japan | 2 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
| Gunma University | 1 |
| Nagoya City University | 1 |
| Nagoya University | 1 |
| National Cancer Centre, Singapore | 1 |
| Ono Pharmaceutical Co., Ltd. | 1 |
| Takeda | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Giant Cell Tumor of Tendon Sheath | 1 |
| Glomerulonephritis, IGA | 1 |
| Neoplasm Metastasis | 1 |
| Parkinson Disease | 1 |
| Recurrence | 1 |
| Thymoma | 1 |
| Thyroid Cancer, Papillary | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.